BioXcel Therapeutics, Inc. (BTAIQ) Return on equity
BioXcel Therapeutics, Inc. (BTAIQ) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-215.9%FY2022
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -215.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BTAIQ financial trends
BTAIQ RevenueBTAIQ Net incomeBTAIQ Net marginBTAIQ Gross profitBTAIQ Gross marginBTAIQ Operating incomeBTAIQ Operating marginBTAIQ Operating cash flowBTAIQ Free cash flowBTAIQ Capital expendituresBTAIQ Stock buybacksBTAIQ Dividends paidBTAIQ Total assetsBTAIQ Total liabilitiesBTAIQ Shareholders’ equityBTAIQ overview →